natgillin/translations-raw huggingface dataset:
Dette særtilbud gælder udelukkende for de mængder, der sælges til dækning af eget behov.
This cut­rate offer applies to quantities needed for customers' own requirements.
Denne »aktion eget behov« blev fulgt op af en rundskrivelse med nedenstående indhold, som Bayer AG den 10./11. juli 1986 sendte til alle tyske Bayo-n-ox-kunder :
This 'own requirements' more was followed up by the following circular which Bayer AG sent to all its German Bayo­n­ox customers on 10 and 11 July 1986:
Bayer AG påstår, at Bayo-n-ox inden den 10./11. juli 1986 i en række tilfælde var blevet forvekslet med andre Olaquindox-præparater af ringere kvalitet.
Bayer AG claims that, before 10 and 11 July 1986, Bayo­n­ox was in a series of instances mixed with other, lower quality Olaquindox preparations.
Bayo-n-ox var endvidere også blevet solgt direkte til dyreavlere og var blevet ulovligt anvendt af disse uden for det tilladte anvendelsesområde i større doseringer til behandlingsformål som middel mod diarré.
It alleges that Bayo­n­ox was also distributed direct to animal owners and used by them improperly outside the approved range of application or in higher doses for therapeutic purposes in animals suffering from diarrhoea.
For at forhindre dette i fremtiden havde virksomheden forpligtet sine kunder til udelukkende at købe Bayo-n-ox til anvendelse i egen fabrik.
So as to prevent this in future, it claims, it required its customers to purchase Bayo­n­ox only for use in their own works.
På denne måde ønskede virksomheden at forhindre krydsleverancer af Bayo-n-ox mellem virksomheder i foderstofindustrien (direkte eller
In this way, it claims, its intention was to prevent cross supplies of Bayo­n­ox from one feedingstuffs undertaking to another (direct or via a dealer) and to reduce the risk of a deterioration in quality through mixture with inferior Olaquindox
På foranledning vil vi hermed gerne i dag bekræfte de eksisterende aftaler vedrørende Bayo-n-ox således :
The amounts of Bayo­n­ox supplied to you are used exclusively to cover your own require­ments in your own works.
Da det i 1983 blev konstateret, at en fransk Bayo-n-ox-kunde var ansvarlig for eksport til Schweiz, blev denne kundes leverancer fra franske Bayer-forhandlere begrænset.
When in 1983 a French Bayo-n-ox customer was identified as the source of exports to Switzerland, the customer's supplies were quantitatively limited by the French Bayer distribution undertaking.
b) Efter udløbet af patentbeskyttelsen i Tyskland
(b) After the end of patent protection in Germany
Efter at Bayer AG's patentbeskyttelse for »Olanquindox«'s udløb i begyndelsen af oktober 1985, og dette tilsætningsstof herefter også blev solgt af andre fabrikanter på det tyske marked, var prisen for Bayo-n-ox i Tyskland [... ] DM pr. kg.
When, at the beginning of October 1985, the patent protection of 'Olaquindox' expired for Bayer AG and the active substance then became available on the German market from other manufacturers as well, the prices for Bayo-n-ox in Germany were DM [... ] per kilogram.
Bayers franske forhandlere blev som følge af den parallelimport, der straks blev iværksat, allerede den 25. oktober 1985 tvunget til at sænke priserne fra [... ] ffr. til [... ] ffr.
Already on 25 October 1985, because of the immediate onset of parallel imports, the French Bayer distribution undertaking was compelled to reduce its prices from FF [... ] to FF [...].
Til trods for at der i vidt omfang blev indrømmet mængderabatter, måtte priserne sænkes yderligere.
Despite the extensive grant of rebates in kind, prices subsequently had to be further cut on a continuous basis.
I øvrigt var krydsleverancer mellem virksomheder inden for foderstofindustrien i strid med § 21 i de tyske foderstofbestemmelser.
Furthermore, Bayer AG argues, provi ding cross supplies to feedingstuff undertakings infringes Article 21 of the German Feedingstuffs Order.
En virksomhed inden for foderstofindustrien, der har fået produktet leveret, ville handle retsstridigt, hvis virksomheden videresolgte Bayo-n-ox til en ikke anerkendt virksomhed.
Any feedingstuffs undertaking supplied by it would be committing an offence if it resupplied Bayo-n-ox to a non-approved undertaking.
Men de ansvarlige inden for Bayer AG ville også handle retsstridigt, hvis de med kendskab til sådanne forseelser leverede Bayo-n-ox til en forhandler.
However, those responsible in Bayer AG would also be committing an offence if, in the knowledge of such infringements, they were to supply a dealer with Bayo-n-ox.
Formålet med de trufne foranstaltninger var »at hindre misbrug af Bayo-n-ox med risiko for mennesker og dyrs sundhed, at undgå forbud mod omsætning og medvirken til forseelser, der er belagt med bødestraf i henhold til den tyske foderstoflovgivning, at undgå erstatningskrav begrundet i produktansvar og endelig at forhindre, at Bayo-n-ox's gode ry og anseelse ville lide overlast som følge af ukontrolleret handel med dette produkt gennem ulovlige distributionskanaler«.
The purpose of the measures taken, it is argued, is 'to prevent uncontrolled trade in Bayo-n-ox through distribution channels that are not legally authorized, so as to prevent any misuse of Bayo-n-ox that might endanger the health of man and beast, to prevent loss of marketability and involvement in offences against German feeding stuffs law that are liable to incur fines, to prevent product liability claims and, lastly, to prevent any adverse effect on the good name and reputation of Bayo-n-ox'.
Bayer AG gør gældende, at der er en ubrydelig sammenhæng mellem rådgivning fra deres specielt uddannede medarbejdere og salg af vækstfremmende midler, som kræver korrekt anvendelse.
Bayer AG argues that counselling by its trained staff and sale of the growth promoter, which requires correct application, form a whole and are inseparable.
I januar 1986 kunne Bayer AG konstatere, at det ikke kun var forhandlere, der var involveret i parallelimporten, men at de store foderstoffirmaer, som for at dække deres behov yderligere byttede råstoffer i Benelux og Frankrig, også var inddraget heri.
In January 1986, Bayer AG realized that not only the trade was involved in the parallel imports, but that large feedingstuffs manufacturers, which in any case exchanged raw materials if and when required in Benelux and in France, were also involved in the transactions.
I en meddelelse fra Bayer AG's juridiske afdeling angives som baggrund for rundskrivelsen, at Bay-n-ox-patentet i Tyskland var udløbet, medens beskyttelsen stadig var gyldig i de andre EF-lande.
In a memo from Bayer AG's legal department, the background to the circular is explained as being the expiry of the Bayo-n-ox patent in Germany, while protection continued to exist in other Community countries.
Dette havde resulteret i en prisforskel mellem Tyskland og disse andre EF-lande, således at enkelte tyske foderstoffabrikanter havde indgået forretninger med importører fra andre EF-lande, der var i strid med den tyske lovgivning på foderstofområdet.
This had led to a price differential between Germany and such other Community countries, resulting in transactions between individual German feedingstuffs manufacturers and importers from other Community countries that were contrary to German law on feedingstuffs.
Handel uden for forhandlersystemet a) Inden udløbet af patentbeskyttelsen i Tyskland
Trade outside the distribution system
DM, men anvender et andet Olaquindoxprodukt til 6,50 DM pr. kg.
(a) Before the end of patent protection in Germany
Allerede i 1981 måtte man nedsætte gennemsnitsprisen for Bayo-n-ox i Frankrig fra [... ] ffr. til [... ] ffr. som følge af import fra Belgien.
Already in 1981, the average price for Bayo-n-ox in France had to be reduced from FF [... ] to FF [ ... ] as a result of imports from Belgium.
I april 1986 standsede man en tilbagekøbsaktion, der var blevet indledt i januar 1986.
In April 1986, a repurchase scheme started in January 1986 was called to a halt.
På grundlag af en nøje inalyse ønskede man at konstatere, fra hvilken tysk kilde det Bayo-n-ox stammede, der var fundet i andre EF-medlemsstater.
A careful analysis was supposed to allow identification of the German source from which the Bayo-n-ox found in the other Member States originated.
Gennem omfattende foranstaltninger, der involverede alle Bayers berørte forhandlere, blev der med (i
As a result of wide-ranging measures in which all the.Bayer distribution undertakings concerned were involved, an attempt was made, with at least some success, to determine the sources of the import.
En vis mængde Bayo-n-ox, der var blevet opkøbt i Holland, stammede fra en leverance af 21. marts 1986 til firmaet [...], selv om denne tyske Bayo-n-ox-kunde over for Bayer AG havde påstået, at varerne kun var købt til eget forbrug (ifølge firmaets oplysninger var der tale om stjålne varer).
A certain quantity of Bayo-n-ox, which had been purchased in the Netherlands, originated from a 21 March 1986 delivery to the firm [...], although the latter had given an undertaking to Bayer AG that it would purchase goods only for its own require ments (according to [...], the goods had been stolen).
(32) foderblandinger samt mellemhandlere skal over­holde de i direktivets bilag III fastsatte bestemmel­ser.
(32) feedingstuffs manufactured with it and intermediaries must comply with the requirements set out in Annex III to the Directive.
Alle medlemsstater offentliggør hvert år en fortegnelse over fabrikanterne.
Each Member State must publish a list of manufacturers annually.
På det sidste afsæt­ningstrin må vækstfremmende stoffer kun sælges til fabrikanter af forblandinger og i form af forblan­dinger kun til fabrikanter af foderblandinger, som opfylder de i bilag III fastsatte mindstekrav.
At the final marketing stage, growth promoters may be sold only to manufacturers of premixes and, in the form of premixes, only to manufacturers of compound feedingstuffs who meet the minimum requirements laid down in Annex III.
Som led i undersøgelserne har Kommissionen på grundlag af artikel 11 i forordning nr. 17 anmodet nogle af Bayers tyske Bayo­n­ox­kunder om oplys­ninger.
As part of its enquiries, the Commission sent requests for information to a number of bayer AG's German Bayo-n-ox customers pursuant to Article 11 of Regulation No 17.
Bayer AG fik kendskab hertil og sendte den 15. december 1987 en skrivelse til sine kunder ('), som ud over en redegørelse for baggrunden for dem af firmaet trufne foranstaltninger havde følgende indhold :
Bayer AG learned of this and, on 15 December 1987, sent a letter to its customers ('), setting out the background to the measures it had taken and containing the following wording :
Olaquindox blev først optaget i bilag II i Kommis­sionens direktiv 76/933/EØF (/).
'Dear Sir or Madam, pursuant to Commission Directive 76/933/EEC (3).
Med de i bilag II nævnte produkter drejer det sig om tilsætningsstof­fer, hvor man endnu ikke har endeligt kendskab til disses indvirkning på dyrs og menneskers sundhed.
The products listed in Annex II are additives whose effect on the health of human beings and animals cannot yet be conclusively assessed.
Medlemsstaternes bemyndigelse til at tillade Olaqu­indox som tilsætningsstof til foderstoffer er blevet forlænget flere gange.
Authorization for Member States to approve Olaquindox as an additive in feedingstuffs was extended on several
Vi anbefaler Dem at besvare Kommissio­nens spørgsmål på nogenlunde følgende måde :
We recommend that you answer the Commission's questions along the following lines : occasions.
Bayer AG gør gældende, at det for virksomheden i denne for produktet fremtidige markedsføring så afgørende fase var den fortsatte adgang til afsæt­ning, der var det vigtigste.
Bayer AG claims that, in this phase which is of such importance for the future marketing of the product, maintenance of the marketability of the product was the primary factor.
Firmaet havde måttet gøre alle disse anstrengelser for at undgå enhver negativ offentlig diskussion om produktet.
It had had to take all possible steps to prevent any negative public discussion of the product.
Der havde især været en risiko i forbindelse med den ukontrollable og ulovlige handel med Bayo­n­ox.
A particular danger had been posed by the uncontrolled trade in Bayo-n-ox contrary to the prohibition laid down.
Efter at De havde bekræftet vor skrivelse af 10./11. juli 1986 fik De den aftale bonus udbe­talt.
Upon your confirmation of our letter of 10 and 11 July 1986, you were paid the bonus as agreed.
De har købt Bayo­n­ox med henblik på forarbejdning i Deres egen fabrik.
You purchased Bayo-n-ox for processing in your own works.
De har ikke forhandlet Bayo­n­ox hverken før eller efter juli 1986.
You did not engage in trade in Bayo-n-ox either before or after July 1986.
De er gået ud fra, at Bayer var interesseret i at forhindre ulovlig praksis i forbindelse med anvendelsen af Bayo­n­ox af kvalitetsmæssige årsager.
You assume that Bayer wanted, for quality protection reasons, to prevent as far as possible legally unauthorized practices in the use of Bayo-n-ox.
Af forretningsdokumenter eksisterer der kun den nævnte rundskrivelse fra Bayer af 10­/11. juli 1986 og Deres bekræftelse af 16. juli 1986«.
The only business documents in this connection are the abovementioned Bayer letter of 10 and 11 July 1986 and your confirmation of 16 July 1986'.
Af hensyn til den fortsatte adgang til at afsætte produktet havde Bayer derfor set sig foranlediget til at træffe alle forholdsregler for at stoppe denne ukontrollable handel med Bayo­n­ox i en situation, hvor der i forvejen var stor risiko for, at produktet ikke på ny ville blive godkendt.
In the interests of maintaining marketability, there fore, Bayer had been obliged to do everything possible to prohibit such uncontrolled trade in Bayo-n-ox in a situation in which the further authorization of the product was in any case extremely doubtful.
Bayer AG anmeldte til Kommissionen den 29. august 1989 en planlagt tilføjelse til leveringsbetin­gelser.
On 29 August 1989, Bayer AG notified the Commission of a planned addition to its terms and conditions of sale.
Genstanden for anmeldelsen er væsentlig forskellig fra genstanden for den nærværende procedure, hvorfor anmeldelsen vil blive vurderet særskilt i en efterfølgende procedure.
This was changed on .... The subject of this notification is significantly different to that of the present proceedings, and shall there fore, be considered in the framework of a subsequent procedure.
I en rundskri­velse dateret den 13. november 1989 trak Bayer AG udtrykkeligt sin rundskrivelse af 10./11. juli 1986 tilbage.
In a circular dated 13 November 1989, Bayer AG expressly withrew its previous circulars dated 10 and 11 July 1986.
Artikel 85, stk. 1
Article 85 (1) of the Treaty
De øjeblikkelige fællesskabsbestemmelser
The current situation regarding Community rules
De aftaler, der var gældende i perioden 10. juli 1986 til 13. november 1989 mellem Bayer AG og de i bilaget nævnte kunder, i henhold til hvilke disse kunder var forpligtet til udelukkende at anvende Bayo­n­ox til dækning af deres eget forbrug i deres egne fabrikker, er uforenelige med fællesmarkedet og forbudt i henhold til artikel 85, stk. 1.
The agreements which were in force from 10 July 1986 to 13 November 1989 between Bayer AG and its customers listed in the Annex, under which such customers were required to use Bayo-n-ox exclusively to cover their own requirements in their own works, are incompatible with the common market and prohibited under Article 85 (1) of the Treatyx.
a) Aftaler mellem virksomheder
(a) Agreements between undertakings
Olaquindox er et tilsætningsstof, der blev opført i direktivets bilag I, og således på ubestemt tid kunne anvendes som tilsætningsstof til foder­stoffer (4).
A number of provisions concerning additives in feedingstuffs laid down in the Member States by law and regulations were harmonized by Council Directive 70/524/EEC (2), as last amended by Commission Directive 88/483/EEC (3), Olaquindox is an additive listed in Annex I to the Directive and may therefore be used for an indefinite period as an additive in feedingstuffs (*).
Fabrikanter af bl.a. vækstfremmende midler og hermed fremstillede forblandinger og
Manufacturers of growth promoters and of premixes and compound
(') Indholdet af skrivelsen til de kunder, som ikke skriftligt havde bekræftet rundskrivelsen af 10711. juli 1986, er tilpasset i overensstemmelse hermed.
(') The content of the letter to customers which did not confirm in writing the circular of 10 and 11 July 1986 is adapted ac cordingly.
(*) Rådets direktiv 87/317/EØF (EFT nr. L 160 af 20. 6. 1987, s.
(') Council Directive 87/317/EEC (OJ No L 160, 20. 6. 1987, p.
34) ; se endvidere afgørelse truffet af EF­Domstolens præsi­
34) ; see also Order of the President of the Court of Justice of the European Communities of 8 April 1987 in Case 65/87-R
dent af 8. april 1987 i sag 65/87­R, Sml. 1987, s. 1691.
Pfizer, not yet reported.
Spørgsmålet, om der allerede inden udsendelsen af rundskrivelsen har eksisteret aftaler med et sådant indhold og i så fald med hvilke aftagere — hvilket episoden i forbindelse med tyveriet ved firmaet [...] (se nr. 31), »retningslinjer for eksportafdelingen« (se nr. 17) og de skriftlige bekræftelser fra de i bilaget under A) og B) nævnte virksomheder tyder på — får stå hen i det uvisse.
The question of whether and with which customers agreements containing such terms already existed before the circular was sent — the events in connection with the theft from the firm [... ] (see paragraph 31), the explanatory instructions for the sales department (see paragraph 17) and the written confirmations provided by the undertakings listed in the Annex under headings A and Β suggest that they did exist — may be left open.
Siden den 10./11. juli 1986 har Bayer AG åbenbart kun leveret Bayo-n-ox til alle kunder til de omtalte særpriser på betingelse af, at varen kun blev anvendt til eget forbrug.
Bayer AG evidently supplied Bayo-n-ox to each customer as from 10 and 11 July 1986 at the rele­vant special prices only subject to the condition that the goods were used for the customer's own requirements.
Alle de i bilaget nævnte Bayer-kunder er i kraft af deres køb af Bayo-n-ox til disse særpriser blevet parter i attaler herom, jf. artikel 85, stk. 1, uanset om de udtrykkeligt har tilkendegivet deres indforståelse hermed eller ej.
Even if they did not expressly state their agreement, all the Bayer AG customers listed in the Annex became parties to agreements within the meaning of Article 85 (1) containing this stipu­lation by the fact of their purchase of bayo-n-ox at such special prices.
Som følge af, at Bayer AG ved siden af særpriserne til dækning af eget forbrug udbød Bayo-n-ox til en pris, hvortil der ikke var hæftet nogen betingelser (se nr. 17), betyder valget af køb til særprisen, at der objektivt var tale om en stiltiende indforståelse med, at produktet blev indkøbt til eget forbrug, med mindre denne betingelse udtrykkeligt blev afvist, hvilket var tilfældet med en af Bayer AG's kunder.
In view of the fact that, in addi­tion to the special prices for own requirements, Bayer AG offered a price for Bayo-n-ox which was not linked to any restriction on disposal (see para­graph 17), the decision to purchase the product at the special prices objectively involves tacit agree­ment to use the product for own requirements, unless this condition was expressly rejected, as one Bayer AG customer did.
Til et i konkur renceretlig henseende uangribeligt selektivt salgssystem hører imidlertid især handelsfrihed inden for nettet af autoriserede forhandlere, og denne frihed eksisterer netop ikke i det foreliggende tilfælde.
However, if it is to be unobjectionable from a competition policy point of view, selective distibution must in particular include freedom to trade within the network of authorized firms. Such freedom is not allowed in the case in point.
Konkurrencebegrænsning c) Konkurrencebegrænsningens formål og følger
(c) Object and effect of restricting competition
Artikel 85, stk. 1, forudsætter, at de pågældende aftaler har til formål eller til følge at begrænse konkurrencen.
Article 85 (1) presupposes that the agreements in question have as their object or effect the restric­tion of competition.
Begrebet »har til formål« har i denne sammenhæng en objektiv betydning. Det drejer sig ikke om parternes subjektive hensigt.
The term 'object' has an objective meaning in this context.
Den for de i bilaget nævnte virksomheder eksisterende forpligtelse til kun at anvende produktet til eget forbrug bevirker, at disse virksomheder ikke må videresælge varen og således heller ikke udføre den til andre EF-medlemsstater.
The own-use requirement applying to the underta­kings listed in the Annex has as its object and effect prevention of the resale of the product by such undertakings and hence also its export by them to other Member States.
Det fremgår alle rede af aftalens ordlyd, at disse virksomheder ikke kan optræde som forhandlere af Bayo-n-ox.
The very wording of the agreement makes it clear that such undertakings are to be ruled out as possible sources of supply for Bayo-n-ox.
De øvrige faktiske eller potentielle forhandleres stilling bliver hermed kunstigt styrket og konkurrencen på udbudssiden begrænset.
The position of the other actual or potential suppliers is thus artifically reinforced and competition on the supply side restricted.
Der ville ganske vist ikke være tale om konkurrencebegrænsning efter artikel 85, stk. 1, hvis det ifølge lovgivningen havde været forbudt for Bayers kunder at videresælge Bayo-n-ox.
However, a restriction of competition within the meaning of Article 85 (1) would not exist, if Bayer AG customers were prohibited by law from trading in Bayo-n-ox.
Forbuddet mod at handle med Bayo-n-ox fremgår direkte af aftalernes ordlyd.
The ban on trading in Bayo-n-ox is directly evident from the wording of the agreements.
I forbindelse med undersøgelsen af forudsætningerne for anvendelse af artikel 85, stk. 1, er Bayer AG's påstand om, at Bayer gennem kundernes forpligtelse til kun at købe til eget forbrug ikke tilsigter nogen konkur rencebegrænsning, uden betydning (se nr. 21).
As far as examination of the applicability of Article 85 (1) is concerned, therefore, Bayer AG's contention that it did not pursue any anti-competitive object in requiring its customers to purchase only for their own requirements (see paragraph 21) is irrelevant.
I øvrigt er konkurrencebegrænsningen også en realitet, fordi tredjemands valgmuligheder ændres som følge af aftalerne.
Furthermore, the ban also has the effect of restric­ting competition, since the scoppe of choice for third parties was affected by the conclusion of the agreements.
d) Konkurrencebegrænsningens mærkbarhed
(d) Appreciability of the restriction of competition
Artikel 85, stk. 3
Article 85 (3) of the Treaty
Som følge af den konkurrence, som Bayo-n-ox i Forbundsrepublikken Tyskland blev udsat for straks efter udløbet af patentbeskyttelsen for Olaquindox og det heraf følgende prisfald, blev alle Bayer AG's tyske kunder en økonomisk interessant forsyningskilde for Bayo-n-ox's aftagere, i det mindste i de tilstødende lande.
Because of the immediate competition which Bayo-n-ox had to face in the Federal Republic of Germany after the expiry of patent protection for Olaquindox and because of the resulting collapse in prices, each of Bayer AG's German customers became an economically attractive source of supply for Bayo-n-ox purchasers, at least in the adjoining Member States.
Den kontraktlige udelukkelse af næsten alle disse forsyningskilder indebærer en mærkbar begrænsning af konkurrencen mellem disse og især de berørte Bayer-forhandlere.
The contractual elimination of almost all of these sources of supply restricts competition appreciably between the latter and the relevant Bayer distribution companies in particular.
De aftaler, der eksisterede mellem Bayer AG og de i bilaget nævnte firmaer, var ikke anmeldt til Kommissionen som foreskrevet i artikel 4, stk. 1, i forordning nr. 17.
The agreements which existed between Bayer AG and the undertakings listed in the Annex were not notified to the Commission in accordance with Article 4 (1) of Regulation No 17.